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Abstract 
Porcine contagious pleuropneumonia caused by Actinobacillus pleuropneumoniae (APP) remains one of the major 
causes of poor growth performance and respiratory disease in pig herds. While the role of antibodies against APP 
has been intensely studied, the porcine T cell response remains poorly characterized. To address this, pigs were 
intranasally infected with APP serotype 2 and euthanized during the acute phase [6–10 days post‑infection (dpi)] or 
the chronic phase of APP infection (27–31 dpi). Lymphocytes isolated from blood, tonsils, lung tissue and tracheo‑
bronchial lymph nodes were analyzed by intracellular cytokine staining (ICS) for IL‑17A, IL‑10 and TNF‑α production 
after in vitro stimulation with crude capsular extract (CCE) of the APP inoculation strain. This was combined with 
cell surface staining for the expression of CD4, CD8α and TCR‑γδ. Clinical records, microbiological investigations and 
pathological findings confirmed the induction of a subclinical APP infection. ICS‑assays revealed the presence of 
APP‑CCE specific CD4+CD8αdim IL‑17A‑producing T cells in blood and lung tissue in most infected animals during 
the acute and chronic phase of infection and a minor fraction of these cells co‑produced TNF‑α. APP‑CCE specific IL‑
17A‑producing γδ T cells could not be found and APP‑CCE specific IL‑10‑producing CD4+ T cells were present in vari‑
ous organs but only in a few infected animals. The frequency of identified putative Th17 cells (CD4+CD8αdimIL‑17A+) 
in lung and blood correlated positively with lung lesion scores and APP‑specific antibody titers during the chronic 
phase. These results suggest a potential role of Th17 cells in the immune pathogenesis of APP infection.
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and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/
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Introduction
Actinobacillus pleuropneumoniae (APP) is a gram nega-
tive bacterium, belonging to the Pasteurellaceae family 
that causes porcine respiratory disease worldwide. The 
outcome of the infection can vary from sudden death 
with bloody nasal discharge to an acute disease with fever 
and coughing that frequently results in chronic infec-
tions [1]. Vaccination and antibiotic based therapies can 
help to reduce the severity of the symptoms and decrease 
the mortality rates, but are not effective in clearing the 
bacteria [2]. In fact, pigs overcoming the acute phase can 
become subclinically infected and persistent carriers, 
harboring APP in tonsils and chronic lung lesions [3]. 
Since 1957, when APP was first reported, most research 
activities were focused on the elucidation of the humoral 
immune response [4–6]. Thereby it also became clear that 
APP developed several strategies to avoid humoral host 
defense mechanisms. For example, in  vitro experiments 
indicated that APP can survive in alveolar macrophages 
[7], has the capacity for enhanced biofilm formation in 
anaerobic conditions [8], and changes the polysaccharide 
composition of the capsule [3]; all possibly contributing 
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to an escape from humoral immunity and to the estab-
lishment of chronic infection in lung tissue and tonsils.
For a more thorough understanding of APP pathogen-
esis and persistence, cell-mediated immune mechanisms 
also need to be taken into focus. In particular, T-cell 
responses may equip the host with additional means to 
combat APP infections, but could also be involved in 
dysfunctional immune responses [9] or could support 
immune escape mechanisms [10]. Hitherto, the T-cell 
mediated immune response to APP has been poorly 
characterized in swine. Early studies indicated the poten-
tial relevance of T cells, because the intensity of a T-cell 
dependent delayed-type hypersensitivity reaction was 
associated with protection against an APP challenge 
infection [11]. In addition, a change in the CD4:CD8 ratio 
in peripheral blood following low-dose APP immuniza-
tion and high-dose APP challenge has been reported, 
but the phenotype of involved cells was not further 
studied [12]. Furthermore, Faldyna et  al. [13] described 
an increase of CD8α− γδ T cells in bronchoalveolar lav-
age fluid (BALF) as well as B-cells in tracheobronchial 
lymph nodes of pigs challenged with APP suggesting a 
role of γδ T cells in this infection. More recently, IL-17 
was shown to be induced on the transcriptional level in 
lungs of pigs affected by APP [14] and it has been dem-
onstrated that CD4+ and γδ T cells are capable to pro-
duce IL-17 in swine [15–17]. From studies in mice and 
humans it is known that IL-17-producing CD4+ T (Th17) 
cells are involved in the clearance of extracellular patho-
gens in peripheral organs by attraction and stimulation of 
neutrophils [18]. There is also some evidence that Th17 
cells can be involved in chronic airway inflammation 
[19]. Moreover, in vivo and in vitro studies with Mannhe-
imia haemolytica, which like APP belongs to the Pasteur-
ellaceae family and induces neutrophilic infiltration in 
the lung, suggested an IL-17 production by bovine γδ T 
cells [20]. Thus we hypothesized that IL-17 production by 
Th17 but also γδ T cells might be involved in the porcine 
immune response to APP. Since the anti-inflammatory 
cytokine IL-10 may support the survival of microor-
ganisms in the host via inhibiting their cell-mediated 
immune response [21–23], we investigated in parallel its 
role in persistence of APP.
To address these issues we developed an APP infec-
tion model and an in vitro stimulation assay making use 
of an APP crude capsular extract (APP-CCE). Cytokine 
production by CD4+ and γδ T cells was investigated by 
intracellular cytokine staining (ICS) of lymphocytes iso-
lated from different host compartments during the acute 
and chronic phase of APP infection. We found that the 
majority of pigs infected with APP harbor APP-CCE spe-
cific IL-17A+ CD4+ T cells in the lung and in the blood 
during the acute and the chronic phase of APP infection. 
In chronically infected animals, the frequency of these 
cells in lung and peripheral blood was found to correlate 
positively with lung lesions and APP-specific antibody 
titers.
Materials and methods
Experimental APP infection model
Thirty 5-week-old male castrated pigs (German Lan-
drace), routinely tested to be negative for APP, porcine 
reproductive and respiratory syndrome virus (PRRSV), 
toxigenic Pasteurella multocida, endo- and ectoparasites, 
were derived from a closed breeding herd of high health 
status in Mecklenburg-Western Pomerania, Germany. 
Animals were moved to Austria, following European 
guidelines on protecting the welfare of animals during 
transport, stated by Regulation (EC) No 1/2005. Upon 
arrival, animals entered a biosafety level 2 facility at the 
University of Veterinary Medicine Vienna, where they 
were kept for the entire duration of the experiment. Ani-
mals were weighed, individually marked with ear tags, 
and then, according to their body weight, divided into a 
control and an infected group of ten and twenty animals 
respectively. Control and infected group were housed 
in separate compartments. Within the infected group, 
animals were assigned to two subgroups of ten animals 
each, which were kept under identical conditions but 
euthanized either 6–10  days post-infection (dpi) (acute 
infected group) or 27–31  dpi (chronic infected group). 
At the time of arrival, the APP-free status of the pigs 
was confirmed by bacteriological examination of nasal 
and tonsillar swabs and by serological testing for anti-
bodies against Apx-IV using the commercially available 
IDEXX APP-ApxIV Ab Test ELISA (IDEXX Laborato-
ries, Westbrook, USA). After 2  weeks of adaptation, at 
day 0 an intranasal spray infection was performed. For 
the infection, an APP biotype 1 serotype 2 strain (Lab 
number C3656/0271/11) was used, isolated originally by 
the Institute of Microbiology, University of Veterinary 
Medicine, Hanover, Germany from a diseased fattening 
pig during an acute outbreak of porcine pleuropneu-
monia in northern Germany [24]. After initial isolation, 
bacteria were animal-passaged once and lab-passaged 
four times in PPLO medium supplemented with NAD. 
Pigs were infected with 2 mL (1 mL into each nostril) of 
bacterial culture containing 2 × 104 CFU/mL. The bacte-
rial culture was vaporized directly into the nostrils of the 
pigs by using a mucosal atomization device (LMA MAD 
Nasal™, Teleflex Medical GmbH, Athlone, Ireland). Con-
trol pigs underwent the same procedure, but received 
2  mL of 154  mM sterile NaCl instead of the bacterial 
culture. Daily clinical examinations were carried out and 
assembled in a clinical score, considering rectal tempera-
ture, presence of dyspnea and/or coughing and changes 
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in behavior (see Additional file  1 for details). Addition-
ally, pig body weights were recorded weekly. To screen 
for presence of APP in the upper respiratory tract, nasal 
and tonsillar swabs were examined at 14 and 21 dpi. At 
the end of the experiment, after animals were euthanized, 
tonsillar tissues were taken instead of swabs. Blood sam-
ples were taken by puncture of the V. cava cranialis or V. 
jugularis on the same days. Sera were used for detection 
of APP 2 specific antibodies, while heparinized samples 
were obtained to isolate peripheral blood mononuclear 
cells (PBMCs). Euthanasia was performed on five consec-
utive days (two infected pigs and one control pig per day) 
in two different time frames: 6–10 dpi and 27–31 dpi for 
the acutely and the chronically infected group, respec-
tively. Within these two periods, animals were randomly 
selected for euthanasia, which was performed by intra-
cardial administration of T61® (T61®: Embutramid, 
Mebezoniumiodid, Tetracainhydrochlorid, 1  mL/10  kg 
BW, MSD, Whitehouse Station, NJ, USA) during anes-
thesia (Narketan®, Stresnil®). All animal procedures were 
approved by the institutional ethics committee, the Advi-
sory Committee for Animal experiments (§12 of Law for 
Animal Experiments, Tierversuchsgesetz—TVG) and 
the Federal Ministry for Science and Research (reference 
number bmwfw GZ 68.205/0138-WF/V/3b/2015).
Gross necropsy and pathological examination
At necropsy, a general pathological examination of the 
carcass was performed, with focus on the respiratory 
tract. Organs of interest for the study were extracted in 
the following order: salivary gland (Glandula mandibu-
laris, GM), tonsils, tracheobronchial lymph node (TBLN) 
and lung. After evaluation of the thoracic cavity, the lung 
was extracted from the chest while paying particular 
attention to the presence of pleural effusion or pleural 
adhesions. Then the severity of the pathological find-
ings was determined using the lung lesion score (LLS) 
by Hannan et al. [25] and using the slaughterhouse pleu-
risy evaluation system (SPES) [26] for assessment of the 
pleura status. After clamping off the left main bronchus, 
the right lung was flushed with 100 mL of 154 mM ster-
ile NaCl for collection of BALF, while tissue samples were 
taken from the dorsal portion of the left caudal lobe. If 
no lesions were detected in this particular area, an addi-
tional sample from another affected part of the lung was 
taken for histologic and bacteriological investigations. 
For histology, samples were fixed in 10% neutral buffered 
formalin, processed in 3-µm-thick paraffin-embedded 
sections and stained with haematoxylin and eosin.
Microbiological investigation
Nasal and tonsillar swabs from living animals and nasal 
swabs, salivary gland, tonsils, tracheobronchial lymph 
node, lung and BALF from euthanized animals were 
investigated for the presence of APP by streaking the 
samples on Columbia sheep blood agar (Oxoid, Vienna, 
Austria). Staphylococcus aureus was used as nurse to 
facilitate the isolation of APP from organs carrying a high 
bacterial background flora, such as tonsils and nose [1]. 
Subsequently, APP was transferred to PPLO agar supple-
mented with 10 mg/L NAD (AppliChem GmbH, Darm-
stadt, Germany). Plates were incubated overnight at 37 °C 
and 5% CO2. Identification of the re-isolated bacteria was 
confirmed by serotype 2 specific PCR, using primers for 
the capsular biosynthesis genes cps2AB [27]. In addition, 
snap frozen tissue samples were examined directly by a 
conventional PCR based on detection of the apxIVA gene 
[28].
Determination of APP 2‑specific antibody titers in serum
Sera obtained prior to infection (day 0), at the time of 
euthanasia and at 14 and 21 dpi were analyzed for anti-
bodies against APP 2 using the commercial Swinecheck® 
APP 2 ELISA (Biovet, St-Hyacinthe, Canada) according 
to the manufacturer’s instructions. Results were recorded 
as S/P ratio, obtained by the ratio between optical density 
(OD) of each sample (S) and the mean OD of the positive 
control (P): ODs/MODp.
Preparation of APP crude capsular extract for in vitro recall 
experiments
To stimulate lymphocytes in  vitro, a crude capsu-
lar extract (CCE) from the APP serotype 2 strain 
C3656/0271/11, which has been used to infect the ani-
mals, was prepared following a modified protocol from 
Wittkowski et al. [29]. In detail, 300 mL liquid cultures 
of APP biotype 1, serotype 2, strain C3656, were grown 
to an OD600 of approximately 0.2 and harvested by cen-
trifugation at 6530  g for 5  min. Aqueous phenol (1%, 
w/v) was added to the harvested bacteria (18  mL per 
gram of bacterial wet weight). Thereafter, the suspen-
sions were shaken for 10 min at 37 °C and transferred to 
conical 25 mL flasks and the solution was gently stirred 
for 4 h at 4 °C. After centrifugation at 21 420 g for 30 min 
at 4 °C, the supernatant was filtrated (0.2 µm, Filtropur, 
Sarstedt, Nümbrecht, Germany), dialyzed against Mil-
liQ-H2O (2–4 L replaced every 4 h during the first day, 
then every 8 h) at 4  °C for 2 days, using 1 kDa MWCO 
membrane (Mini Dialysis Kit, GE Healthcare) and finally 
lyophilized overnight. To preserve the integrity of poten-
tial immunogenic proteins in the capsular extract, no 
further purification was performed. Lyophilized sam-
ples were dissolved in phosphate buffered saline (PBS) 
to reach a final concentration of 1  mg/mL. The stimu-
lus was tested for potential toxicity in ConA-stimulated 
(3 µg/mL) PBMCs labelled with violet proliferation dye 
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as described elsewhere [30]. After 4  days of cultiva-
tion, PBMCs were harvested and stained with Live/
Dead® Near-IR stain kit (Invitrogen, Carlsbad, CA, USA) 
according to manufacturer’s instructions and subjected 
to flow cytometry (FCM). Frequencies of dead cells and 
proliferating cells were determined and by a dose titra-
tion of the CCE, the optimal working concentration was 
found to be 4 µg/mL.
Sample collection and isolation of lymphocytes
Blood samples were collected in Lithium-Heparin tubes 
(Primavette®, KABE Labortechnik, Nümbrecht, Ger-
many) prior to infection (day 0), at 14 and 21 dpi and at 
the time of death. PBMCs were isolated by density gradi-
ent centrifugation (Pancoll human, density 1.077  g/mL, 
PAN Biotech, Aidenbach, Germany) as described else-
where [31]. Tonsils and tracheobronchial lymph nodes 
were subjected to a procedure for isolation of lympho-
cytes as previously described [30].
For isolation of lymphocytes from lung tissue, a block 
of tissue (approx. 4 × 3 × 2 cm) from the dorsal portion 
of the left caudal lobe was cut into small pieces (approx. 
3  ×  3  ×  3  mm) and lymphocytes were isolated as 
described elsewhere [32]. Cells from the various tissues 
and blood were counted and suspended in cell culture 
medium (RPMI1640 with stable glutamine supplemented 
with 10% FCS, 100 IU/mL penicillin, 100 µg/mL strepto-
mycin, all from PAN Biotech and 90 µg/mL gentamicin, 
from Sigma-Aldrich, Schnelldorf, Germany) for in  vitro 
cultivation. To standardize the isolation of lymphocytes 
from lung tissue, we decided to sample a defined region 
of the lung, independently of the presence of lesions. The 
dorsal portion of the left caudal lobe was selected for this 
purpose, since the caudal lobes have been described to be 
a common site for APP lesions [33] but the right lung was 
washed for the collection of BALF.
Histopathological analysis of lung tissue
Lung samples for histopathological analysis from acutely 
and chronically infected animals were fixed in neutral 
buffered formalin and embedded in paraffin wax. Tissue 
slides were routinely stained with hematoxylin and eosin 
and examined by a pathologist blinded to the different 
treatment groups. The samples were located adjacent to 
tissue used for lymphocyte isolation. Histopathological 
lesions associated with porcine pleuropneumonia, such 
as tissue necrosis, neutrophilic, histiocytic and lympho-
cytic infiltration, vascular leakage (including edema, 
bleeding, and fibrin in tissue or air spaces) and fibroplasia 
were graded (0 = not present, 1 = low grade, 2 = moder-
ate grade, 3 = high grade).
In vitro stimulation of lymphocytes
Freshly isolated cells from lung, blood, tracheobron-
chial lymph nodes and tonsils were stimulated in  vitro 
with APP-CCE (4  µg/mL) for 18  h at 37  °C in 5% CO2. 
Cells were cultured in round-bottomed 96-well plates, at 
5 × 105 cells per well, in a volume of 200 µL. Four hours 
prior to harvesting the cells, Brefeldin A (BD GolgiPlug™, 
BD Biosciences, San Jose, CA, USA) was added at a final 
concentration of 1 µg/mL. In parallel, cells incubated in 
cell culture medium only served as a negative control. As 
a positive control for cytokine production, a further set of 
cells was cultivated in cell culture medium overnight but 
stimulated with phorbol 12-myristate 13-acetate (PMA; 
50  ng/mL; Sigma-Aldrich) and Ionomycin (500  ng/mL; 
Sigma-Aldrich) during the last 4 h of incubation.
Intracellular cytokine staining and FCM analysis
For FCM staining, cells were harvested and resuspended 
in PBS (without Ca2+/Mg2+) supplemented with 3% FCS. 
Monoclonal antibodies (mAbs) and secondary reagents 
that were used for cell surface staining and subsequent 
intracellular cytokine staining are listed in Table 1. Stain-
ing was performed in 96-well round-bottom plates with 
all incubation steps lasting for 20  min at 4  °C. For dis-
crimination of dead cells, Live/Dead® Near-IR stain kit 
(Invitrogen) was used. To fix and permeabilize the cells, 
BD Cytofix/Cytoperm and BD Perm/Wash (BD Bio-
sciences, CA, USA) was employed according to manufac-
turer’s instructions.
FCM samples were analyzed on a FACSCanto™ II 
flow cytometer (BD Biosciences) equipped with three 
lasers (405, 488 and 633 nm). For automatic calculation 
of the compensation, single-stain samples were pre-
pared. Between 5 ×  105 and 1 ×  106 lymphocytes were 
recorded per sample. Gating of the lymphocytes, doublet 
discrimination and dead-cell exclusion were performed 
for all samples as displayed in Additional file 2. Data were 
processed by FACSDiva software (Version 6.1.3 BD Bio-
sciences) and transferred to Microsoft Excel (Office 2010; 
Microsoft, Redmond, WA, USA) for further calculations 
and preparation of graphs.
Statistical analysis
Spearman’s rank correlation test was used to investigate 
the correlation between the frequency of Th17 cells and 
disease parameters in individual pigs. Spearman’s rank 
correlation coefficients (ρ) and corresponding p val-
ues were calculated in SPSS software (2011, IBM, SPSS 
Statistics for Windows, Version 20.0, Armonk, NY, 
IBM Corp.). SPSS was also applied to produce correla-
tion graphs. For further elaboration of graphs, Inkscape 
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(Version 0.91; Free and Open Source Software licensed 
under the GPL) was used.
Results
Establishment of an infection model for APP subclinical 
infection
To confirm the establishment of a subclinical APP infec-
tion in the pigs of our study, bacteriological and clinical 
parameters were investigated (Figure  1). APP could be 
isolated from the nose of the majority of infected animals 
both from the acute (6–10  dpi) and from the chronic 
period (27–31 dpi) (Figure 1A). Animals belonging to the 
latter group were additionally tested at 14 and 21 dpi, for 
weekly monitoring. The nasal swabs of some of these ani-
mals were positive during weekly monitoring but not at 
the time of death (indicated by a § in Figure 1A). Isolation 
of APP from tonsils was often impaired by overgrowth of 
contaminating flora, but for the majority of animals from 
the chronic phase (8 out of 10) APP could be identified by 
PCR. At the early endpoint (6–10 dpi), the location from 
which APP was most frequently isolated was the lung, 
with 7 positive samples out of 10. In contrast, at the late 
endpoint (27–31 dpi) only 1 out of 10 samples was posi-
tive in the lung. APP was detected in BALF and TBLN of 
only one animal, which died suddenly at 8 dpi (#19). APP 
could not be detected in salivary glands (G. mandibula-
ris, GM) of any animal.
Macroscopically visible lung tissue alterations were 
highly variable, which is partially reflected by the lung 
lesion and SPES scores (Figure  1B; Additional file  3 for 
representative animals). On average, LLS scores from 
animals sacrificed during the acute phase were higher 
than during the chronic phase. Typical histopathological 
findings indicating porcine pleuropneumonia were found 
in infected pigs varying from acute (hyperemia, edema, 
neutrophilic infiltration) to chronic (sequestration of 
necrotic areas by a mixed inflammatory infiltrate and 
fibroplasia) inflammatory tissue alterations (Additional 
file 4).
To evaluate the health status of the pigs, rectal tem-
perature was measured daily together with other clini-
cal parameters. Generally, infected animals developed 
clinical symptoms like dyspnea and coughing and were 
more lethargic than controls within the first 10  dpi. No 
significant differences in average daily weight gain were 
observed between infected (mean 724.7  g  ±  standard 
deviation of 92.6  g) and control (785.3  g  ±  standard 
deviation of 130.7  g) animals during the first 3  weeks 
post infection. Body temperature of infected animals 
started rising towards 40 °C immediately after the day of 
infection (day 0), with some animals reaching high tem-
perature levels within 1–10  dpi (Figure  1C). Then, the 
rectal temperature stabilized between 39.5 and 40 °C for 
2 weeks to finally align with the levels of control animals 
at the end of the study period (25–31 dpi). In parallel, the 
APP 2-specific humoral response was evaluated through-
out the experiment (Figure 1D). Most of the infected ani-
mals produced antibodies against APP 2 after 14  days, 
i.e., antibodies were only detectable in animals that sur-
vived until the chronic phase of infection. No APP 2 anti-
bodies were detectable in control animals at any time 
point.
Production of IL‑17A and/or TNF‑α by CD4+ T cells 
in response to APP‑CCE
For characterization of the T-cell mediated immune 
response, freshly isolated cells from lung, PBMCs, TBLN 
and tonsils were subjected to in  vitro stimulation with 
Table 1 Antibody panels
a Goat Anti-Mouse IgG2a-PE-Cy7, SouthernBiotech.
b Brilliant Violet 421™ Streptavidin, BioLegend.
c Goat Anti-Mouse IgG2b-AlexaFluor647, Invitrogen.
d Goat Anti-Mouse IgG1-PE, SouthernBiotech.
Antigen Clone Isotype Fluorochrome Labelling strategy Source of primary Ab
Intracellular cytokine staining for IL‑17A and TNF‑α
 CD4 74‑12‑4 IgG2b PerCP‑Cy5.5 Directly conjugated BD Biosciences
 CD8α 11/295/33 IgG2a Pe‑Cy7 Secondary antibodya In house
 TCR‑γδ PPT16 IgG2b BV421 Biotin–streptavidinb In house
 IL‑17A SCPL1362 IgG1 Alexa647 Directly conjugated BD Biosciences
 TNF‑α MAb11 IgG1 BV605 Directly conjugated BioLegend
Intracellular cytokine staining for IL‑10
 CD4 74‑12‑4 IgG2b Alexa647 Secondary antibodyc In house
 CD8α 11/295/33 IgG2a BV421 Biotin–streptavidinb In house
IL‑10 945A 4C4 37B1 IgG1 PE Secondary antibodyd Invitrogen
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APP-CCE of APP 2 followed by ICS for IL-17A and TNF-
α. Medium- and PMA/Ionomycin-stimulated cultures 
served as negative and positive controls, respectively. 
Total living lymphocytes were gated and analyzed for 
CD4 expression and IL-17A production (Additional 
files 2A–D). A considerable variability in frequencies of 
Infected animals 
Acute (6-10dpi) Chronic (27-31dpi) 
Animal# 1 2 3 4 5 19 7 8 13 15 11 6 9 10 12 14 16 17 18 20






LLS  5.9 0.8 5.9 2.5 2.9 17 0  0   3.4  2.9  2.9 1.3  0  0  2.9  1.8 1.6 1.9 0 1.3 
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APP isolated (endpoint) § APP isolated (14/21dpi) PCR+ Isolation and PCR+ no APP 
lortnocdetcefni
Figure 1 Microbiological investigation, lung pathology, clinical signs and antibody titers of APP-infected pigs. A The presence of APP 
was investigated at different host locations during necropsy (GM, Glandula mandibularis; TBLN, tracheobronchial lymph node; BALF, bronchoalveolar 
lavage fluid). Red boxes indicate APP detection by agar isolation, orange boxes indicate APP detection by PCR and orange boxes with red lines indi‑
cate positive results by both techniques. Green boxes indicate negative findings for APP. Results shown in the table refer to sampling on the day of 
euthanasia. The nasal swabs of animals #11, 9, 12, 16 and 17 were tested positive only on day 14 and/or 21 pi. This is indicated by red boxes with §. 
B Pathology of the lung was assessed by lung lesion score (LLS) for the lung tissue and by slaughterhouse pleurisy evaluation system (SPES) for the 
pleura. C Rectal temperatures were measured daily in both infected (colored lines) and control (black lines) animals. Body temperature of 40 °C or 
higher was considered as fever (red line). D Humoral response against APP serotype 2. Data are expressed as a ratio between optical density of the 
sample (ODs) and the mean of the optical density of the positive control (MODp). Colored lines in the left graph show ratios for infected animals, 
black lines in the right graph indicate ratios from sera of control animals.
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IL-17A+ CD4+ T cells was found between different ani-
mals and organs following APP-CCE stimulation (Fig-
ure  2). Figure  2A shows representative data of IL-17A 
production and CD4 expression in lung-derived lympho-
cytes isolated from different animals during the acute and 
chronic phase. For each time point, original FCM data 
from one animal with a high and a low frequency of APP-
CCE-responsive IL-17A+ CD4+ T cells is shown. In addi-
tion, respective contour plots for lymphocytes from an 
APP-infected but apparently non-responding animal (fre-
quency of IL-17A+ CD4+ T cells was higher or at the same 
level for medium stimulation as compared to APP-CCE 
stimulation) as well as an animal from the control group 
are presented. Following PMA/Ionomycin stimulation IL-
17A production was found in a subpopulation of CD4+ 
T cells from all animals. Similar findings were obtained 
in PBMC cultures, albeit frequencies of IL-17A+ CD4+ 
T cells were somewhat lower (Additional file 5). Overall, 
the highest number of animals with elevated frequencies 
of APP-CCE reactive-IL-17A+ CD4+ T cells was found 
within lung and PBMCs (Figure  2B). During the acute 
phase the frequencies of IL-17A+ CD4+ T cells in the lung 
were substantially higher in five out of nine animals com-
pared to the control animals. This was similar during the 
chronic phase, with two animals (#11, #12) showing even 
increased frequencies of IL-17A+ CD4+ T cells. Within 
PBMCs the number of responding animals was similar to 
the lung during the acute phase but, later in the chronic 
phase, the median of the frequency of IL-17A+ CD4+ T 
cells dropped down to control levels. In TBLN and tonsils, 
CD4+ T cells of only a few infected animals responded 
with IL-17A production to APP-CCE stimulation, regard-
less of the time post infection (Figure 2B).
Expression of CD8α is correlated with activation and/
or memory formation of porcine CD4+ T cells [34] and 
following PMA/Ionomycin stimulation, IL-17A produc-
ing CD4+ T cells mainly have a CD8α+ phenotype [17]. 
We therefore analyzed CD8α expression and IL-17A 
production in gated CD4+ T cells following APP-CCE 
stimulation (Figure  3; Additional file  6). In the lungs of 
animals belonging to the acute group, the majority of 
IL-17A+ CD4+ T cells following APP-CCE and PMA/
Ionomycin stimulation were CD8αdim, whereas in the 
chronic phase CD8α expression tended to be higher and 
this applied equally to APP-CCE and PMA/Ionomycin 
stimulated cells (Figure 3). Similar results were obtained 
with PBMCs albeit here an up-regulation of CD8α in 
IL-17A-producing CD4+ T cells from the acute to the 
chronic phase was less obvious (Additional file 6).
Next, we analyzed co-production of IL-17A and TNF-α 
within APP-CCE-stimulated CD4+ T cells (Figure  4; 
Additional file  7; for gating strategy see Additional files 
2E  and F), since frequent co-production of TNF-α has 
been observed in PMA/Ionomycin-stimulated porcine 
IL-17A+ CD4+ T cells [17]. The majority of IL-17A-pro-
ducing CD4+ T cells isolated from lung tissue (Figure 4) 
or within PBMC (Additional file  7) did not co-produce 
TNF-α following APP-CCE stimulation (Figure 4A; Addi-
tional file 7A, indicated by arrowhead 1). In contrast, but 
in accordance with previously published data [17] follow-
ing PMA/Ionomycin stimulation most IL-17A+ CD4+ T 
cells co-produced TNF-α (Figure 4A; Additional file 7A, 
arrowhead 2). Despite low frequencies for the majority of 
APP-infected animals, a tendency of higher frequencies 
of TNF-α+ IL-17A+ CD4+ T cells was found within lym-
phocytes from APP-infected pigs compared to control 
animals following APP-CCE stimulation. This applied 
to cells isolated from lung tissue (Figure  4B) and blood 
(Additional file 7B).
APP‑CCE stimulation induced production of IL‑17A by a 
subset of lymphocytes that is neither TCR‑γδ+ nor CD4+
After stimulation with APP-CCE, at least for some ani-
mals a considerable number of CD4− cells showed the 
ability to produce IL-17A in parallel to CD4+ T cells (Fig-
ure 2A). This finding was more prominent in the lung, but 
it was detected also in PBMCs (Additional file 5). Since 
porcine γδ T cells were previously identified as potential 
IL-17A producers following PMA/Ionomycin stimulation 
[16], we hypothesized that these cells might also contrib-
ute to IL-17A production following APP-CCE stimula-
tion. Hence, CD4− cells were further gated for expression 
of TCR-γδ and IL-17A (Additional files 2E and G). Inter-
estingly, these IL-17A-producing cells induced by APP-
CCE stimulation were TCR-γδ− (Figure  5; Additional 
file 8, arrowhead 1). However, they were also present in 
lymphocytes isolated from control animals (Figure  5; 
Additional file  8, last column), which seems to indicate 
that these cells did not require a preceding in vivo prim-
ing by APP. Their frequency was quite variable between 
individual animals but mostly exceeded the very low fre-
quency of IL-17A-producing CD4− TCR-γδ− cells iden-
tified in medium stimulated cultures. Following PMA/
Ionomycin stimulation, IL-17A-producing γδ T cells 
could be identified (Figure  5; Additional file  8, bottom 
panel, arrowhead 2), although IL-17A producing cells 
isolated from lung tissue showed a dim expression of 
TCR-γδ. Overall, this confirms the potential of porcine 
γδ T cells for IL-17A production but our data suggests 
that APP-CCE stimulation does not induce IL-17A pro-
duction in this prominent porcine T-cell subset.
Inconsistent IL‑10 production by CD4+ T cells 
following APP‑CCE stimulation
To investigate a potential induction of IL-10-producing 
lymphocytes in our APP-CCE in vitro stimulation assay 
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the production of IL-10 was analyzed in parallel samples 
to that of IL-17A/TNF-α in combination with cell sur-
face staining for CD4 and CD8α expression. Overall, with 
the exception of cells isolated from the APP-infected pig 
#17, frequencies of IL-10+ CD4+ T cells were low and 
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High Resp. Low  Resp. Non Resp. Control High Resp. Low  Resp. 
#5 #8 #12 #16 #6 #23 
Figure 2 APP-CCE specific IL-17A-producing CD4+ T cells in lung, blood, tracheobronchial lymph nodes and tonsils. Cells isolated 
from lung, blood (PBMC), tracheobronchial lymph nodes (TBLN) and tonsils were incubated overnight with APP crude capsular extract (APP‑CCE), 
medium or PMA/Ionomycin. Living lymphocytes were gated (not shown; see Additional file 1) and further analyzed for the expression of IL‑17A 
and CD4. A For the lung, data from representative animals from different groups are displayed: #5 and #8 for the acute phase, designated as “high 
responder” and “low responder” respectively; #12 and #16 for the chronic phase designated as “high responder” and “low responder” respectively; 
#6, designated as non‑responder and control #23. Approximately 1 × 106 (APP and medium) and 2 × 105 (PMA/Ionomycin) cells are shown in the 
contour plots. Numbers displayed within the contour plots indicate the percentages of IL‑17A+ CD4+ T cells within total CD4+ T cells. B Frequency 
of IL‑17A+ CD4+ T cells within total CD4+ T cells in lung, blood (PBMC), tracheobronchial lymph node (TBLN) and tonsils of all infected animals 
(red dots) and control animals (blue dots) during acute and chronic phase. Numbers next to colored dots indicate numbers of individual animals. 
Median percent values are indicated by black bars. Medium‑corrected percent values are presented (% of IL‑17A+ CD4+ T cells within total CD4+ T 
cells for APP‑CCE stimulation minus % of IL‑17A+ CD4+ T cells within total CD4+ T cells for medium incubation).
Page 9 of 16Sassu et al. Vet Res  (2017) 48:4 
during the acute and the chronic phase as well as differ-
ent organs (Figure 6). However, in cells of some animals, 
the frequency of IL-10+ CD4+ T cells was at least two-
fold higher following APP-CCE stimulation compared 
to medium and was also higher compared to that from 
control animals. This applied to animals #3, 5 and 7 in the 
lung during the acute phase and animal #18 during the 
chronic phase (see also Figure 6A for original FCM data). 
Similarly, within PBMCs, animals #7, 4, 5, 11 and 15 
appeared to have APP-CCE-reactive IL-10+ CD4+ T cells 
above background levels (see also Additional file  9 for 
original FCM data). Isolated during the chronic phase, 
CD4+ T cells from animal #17 showed an exceptionally 
high frequency of IL-10 producing cells after APP-CCE 
stimulation, both in lung and in tonsils (Figures 6A and 
B). The reasons for this are unknown. CD4− IL-10-pro-
ducing cells were identified (Figure 6A; Additional file 9 
and data not shown) but similar frequencies were found 
for APP-CCE- and medium-stimulated cultures.
Frequency of IL‑17A+ CD4+ T cells correlates positively 
with disease parameters during the chronic phase 
of infection
We next investigated whether the variable frequency of 
APP-CCE-reactive IL-17A+ CD4+ T cells between dif-
ferent animals and organs correlated with parameters of 
APP pathogenesis and also APP-specific antibody titers. 
In chronically infected animals, the frequency of APP-
CCE-reactive IL-17A+ CD4+ T cells isolated from the 
lung showed a positive correlation with LLS (Spearman’s 
rho  =  0.858; p  =  0.001) and with APP 2 antibody titers 
(Spearman’s rho = 0.632, p = 0.05). For IL-17A+CD4+ T 
cells within PBMCs of the same group of animals also a 
positive correlation with LLS and antibody titers was found 
(Spearman’s rho of 0.679; p = 0.031 and 0.742, p = 0.014 
respectively) (Figure  7). In contrast, for acutely infected 
animals no positive correlation of IL-17A+ CD4+ T cells 
isolated from lung or blood with the LLS was found (Addi-
tional file  10). Additionally, the frequencies of APP-CCE-
reactive IL-17A+ CD4+ T cells isolated from the lung and 
blood were tested for correlation with histological scores of 
the lung tissue adjacent to tissue used for isolation of lym-
phocytes (Additional file 11). A total histological score for 
each sample was calculated by summing up all analyzed 
parameters (see Additional file 4) and was used to calculate 
the correlation. No significant correlation was found, which 
may indicate that APP-CCE-reactive IL-17A+ CD4+ T cells 
have a general capacity for lung homing.
Discussion
The main focus of the study was to characterize the 
cytokine response of T cells isolated from pigs under-
going either an acute or a subclinical APP infection. To 
address this question, we first aimed to establish an infec-
tion model that evokes typical but not lethal APP disease 
symptoms and induces a status of subclinical infection. 
Most of the experimental infections described in the lit-









High Resp. Low  Resp. Non Resp. Control High Resp. Low  Resp. 
#5 #8 #12 #16 #6 #23 
Figure 3 Expression of CD8α by IL-17A+ CD4+ T cells in the lung. Cells isolated from lung tissue were incubated overnight with APP crude 
capsular extract (APP‑CCE), medium or PMA/Ionomycin and subsequently analyzed for CD4, CD8α and IL‑17A expression by FCM. Living CD4+ T 
cells were gated (not shown; see Additional file 1) and subsequently investigated for expression of CD8α and IL‑17A. Data from the same animals as 
in Figure 2 are shown. Approximately 1 × 105 (APP and medium) and 5 × 104 (PMA/Ionomycin) CD4+ T cells are shown in the contour plots.
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APP infection [35–37]. The outcome of APP infection 
is depending on the route of infection, the dose and the 
virulence of the strain [38]. Baarsch et  al. [39] demon-
strated that the route of infection influences the distri-
bution of lung lesions, with the intranasal inoculation 
provoking mainly unilateral lesions and the endotra-
cheal infection inducing diffuse bilateral pneumonia. To 
better mimic natural infection, we decided to perform 
an intranasal inoculation. To avoid loss of bacterial solu-
tion by swallowing or miscalculation of the actual infec-
tion dose by aerosol administration, the inoculum was 
sprayed directly into the nostrils rather than deposited as 
a liquid. Considering that vaporizing the bacterial solu-
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#5 #8 #12 #16 #6 #23 
Figure 4 Co-production of TNF-α and IL-17A by CD4+ T cells in the lung. Phenotyping and intracellular cytokine staining were performed on 
cells from lung tissue following overnight in vitro stimulation (APP‑CCE, medium, PMA/Ionomycin). A Living CD4+ T cells were gated (not shown; 
see Additional file 1) and further analyzed for production of TNF‑α and IL‑17A. Data from the same animals as in Figure 2 are shown. Approximately 
1 × 105 (APP and medium) and 5 × 104 (PMA/Ionomycin) cells are shown in the contour plots. B Frequency of IL‑17A/TNFα co‑producing CD4+ 
T cells in lung tissue of infected animals (red dots) and control animals (blue dots) during acute and chronic phase. Numbers next to colored dots 
indicate numbers of individual animals. Median percent values are indicated by black bars. Medium‑corrected percent values are presented (% of 
IL‑17A+ TNF‑α+ cells within total CD4+ T cells for APP‑CCE stimulation minus  % of IL‑17A+ TNF‑α+ cells within total CD4+ T cells for medium‑incu‑
bation). Arrow heads are introduced in the main text.
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APP reaching the alveoli [1], the infection dose was kept 
to low levels to avoid the induction of a per-acute form. 
The endpoints where chosen to compare acute and sub-
clinical phase of infection. We hypothesized that at days 
6–10 a first activation of T cells may be measurable like 
previously reported for acute influenza A virus infection 
[40]. Additionally, the median duration of APP tonsillar 
colonization was reported around 7–8 weeks post-infec-
tion (pi) [41] leading to the assumption that APP would 
still be present at days 27–31 pi causing a subclinical 
infection. Pathological and clinical findings confirmed 
the establishment of a bi-phasic course of infection. The 
variety of rectal temperatures obtained during the acute 
phase paralleled with the variety of lung lesions observed 
at necropsy, with patterns ranging from severe and diffuse 
pneumonia with dark red–purple areas (per-acute), local-
ized necrotizing pneumonia accompanied by fibrinous 
pleurisy (acute) to firm adhesive pleurisy and organized 
sequestra (chronic). On the opposite, during the chronic 
phase animals showed more uniform lesions and their 
body temperatures dropped down to physiological levels. 
These results indicate that our infection model success-
fully induced an acute infection that resolved into a sub-
clinical one. Furthermore, this dichotomy could also be 
found by analyzing the presence of APP at different host 
compartments. During the acute phase, APP was mostly 
detected in the lung (7 out of 10), and hardly in the tonsils 
(3 out of 10). During the chronic phase, only one animal 
was positive in the lung, whereas in the tonsils 8 out of 10 
tested positive. This might indicate a shift in the tropism 
of the bacteria from the lower to the upper respiratory 
tract and might be interpreted as an attempt of the bacte-
ria to escape from the local immune response in the lung.
In frame of this study, we developed an in vitro stimula-
tion assay using a crude capsular extract of APP. This assay 
was used to investigate the production of IL-17A, TNF-α 
and IL-10 in lymphocytes isolated from lung, peripheral 
blood, tracheobronchial lymph node and tonsil. Our data 
suggest that IL-17A-producing CD4+ T cells are induced in 
the lung tissue and blood of most APP-infected pigs. IL-17 
is a pro-inflammatory cytokine, known to play a role in pul-
monary infection and neutrophil recruitment [42, 43]. Its 
role in veterinary animal species [44] and its up-regulation 
in the surroundings of APP colonies in affected lung lesions 
on mRNA level have been previously described [14]. Thus 
it is tempting to speculate that the APP-CCE-reactive IL-
17A producing CD4+ T cells identified in this study repre-
sent APP-specific Th17 cells. The specificity of these cells is 
corroborated by two findings. First, similar to PMA/Iono-
mycin-induced IL-17A+ CD4+ T cells, these putative APP-
specific Th17 cells expressed low or intermediate levels of 
CD8α. Its expression in porcine CD4+ T cells is related to 
activation and/or memory formation [34, 45]. Therefore, 
this CD8α expression can be interpreted as an indication 
that APP-CCE-reactive IL-17A-producing CD4+ T cells 












High Resp. Low  Resp. Non Resp. Control High Resp. Low  Resp. 
#5 #8 #12 #16 #6 #23 
Figure 5 Production of IL-17A by non-CD4+ cells and γδ T cells in the lung. Cells isolated from lung tissue were incubated overnight with 
APP‑CCE, medium or PMA/Ionomycin and subsequently analyzed for CD4, TCR‑γδ and IL‑17A expression by FCM. Living lymphocytes excluding 
CD4+ T cells (not shown; see Additional file 1) were gated and further analyzed for expression of IL‑17A and TCR‑γδ. Data from the same animals as 
in Figure 2 are shown. Approximately 1 × 106 (APP and medium) and 2 × 105 (PMA/Ionomycin) cells are shown in the contour plots. Arrow heads 
are introduced in the main text.
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reactive IL-17A producing CD4+ T cells were nearly com-
pletely absent in lymphocytes isolated from control pigs, 
indicating that APP-naive CD4+ T cells did not respond to 
in vitro stimulation with APP-CCE.
Human [46] and porcine [17] CD4+ T cells have the 
capacity to co-produce IL-17A and TNF-α following PMA/
Ionomycin stimulation. Furthermore, a synergistic effect 
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#5 #17 #18 #6 #23 
Figure 6 APP-CCE specific IL-10-producing CD4+ T cells in lung, peripheral blood, tracheobronchial lymph nodes and tonsils. Cells 
isolated from lung, blood (PBMC), tracheobronchial lymph nodes (TBLN) and tonsils were incubated overnight with APP‑CCE, medium or PMA/
Ionomycin and subsequently analyzed by FCM. Living cells were gated (not shown; see Additional file 1) and further analyzed for expression of IL‑10 
and CD4. A For the lung, data from representative animals from different groups are displayed: #5 for the acute phase, designated as “responder”; 
#17 and #18 for the chronic phase, designated as “outlier” and “responder”, respectively; #6, designated as “non‑responder” and control pig #23. 
Approximately 5 × 105 (APP and medium) and 1.5 × 105 (PMA/Ionomycin) cells are shown in the contour plots. Numbers displayed within the 
contour plots indicate the percentage of IL‑10+ CD4+ T cells within total CD4+ T cells. B Frequency of IL‑10+ CD4+ T cells in lung, PBMC, TBLN and 
tonsils of infected animals (red dots) and control animals (blue dots) during acute and chronic phase. Numbers next to colored dots indicate num‑
bers of individual animals. Median percent values are indicated by black bars. Medium‑corrected percent values are presented (% of IL‑10+ CD4+ T 
cells within total CD4+ T cells for APP‑CCE stimulation minus % of IL‑10+ CD4+ T cells within total CD4+ T cells for medium incubation).
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neutrophil migration [47]. Also, TNF-α is known to play a 
major role in the immune-pathogenesis of APP infection 
[35, 48]. Following APP-CCE stimulation, we found that 
the majority of CD4+ T cells that produced IL-17A did not 
co-produce TNF-α. This suggests that CD4+ T cells are not 
a main source of TNF-α during APP infection.
Interestingly, a small subset of CD4− TCR-γδ− cells 
showed production of IL-17A upon APP-CCE stimula-
tion but was also identified in control animals. Innate 
sources of IL-17 are described [49] such us iNKT cells 
[50], NK cells [51] and innate lymphoid cells type 3 
(ILC3) [52]. To affirm that the population revealed in our 
study is actually belonging to one of the subsets men-
tioned above, further investigations would be needed.
For several persistent pathogens like Mycobacterium 
tuberculosis [21], Leishmania spp. [23] and Toxoplasma 
gondii [22], IL-10 has been reported to impair their 
clearance by influencing the delicate balance between sup-
pression and activation of host immune responses. In this 
study we therefore evaluated the production of IL-10 by 
CD4+ T cells in different organs but a specific induction 
upon APP-CCE stimulation was found only in few animals 
and frequencies of IL-10+ CD4+ T cells were rather low. In 
a previous study, IL-10 mRNA was predominantly found 
within lung lesions of APP-infected pigs but was only min-
imal in non-affected areas. [53]. Of note, lung tissue sam-
ples in our study were derived from a defined anatomic 
area (dorsal portion of the left caudal lobe) and only in a 
single animal (#11) sequestra were included in that area. 
The frequency of IL-10-producing CD4+ T cells derived 
from this animal was high in both APP-CCE-(0.17%) 
and medium-(0.17%) stimulated cultures, resulting in a 
medium-corrected value of zero (Figure  6B, lung). Thus, 
we cannot exclude a potential role of IL-10 in the immune 
























































































Figure 7 Correlation of the frequency of IL-17A+ CD4+ T cells with lung lesion score and antibody titers during the chronic phase. 
Scatterplots show correlation of the frequency of IL‑17A+ CD4+ T cells isolated from lung and blood with lung lesion score (top panel) and antibody 
titer (bottom panel) in chronically infected animals. Antibody titer is expressed as a ratio between optical density of the sample (ODs) and the mean 
of the optical density of the positive control (MODp). Spearman’s Rank Correlation coefficients (ρ) are displayed above each scatterplot.
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pathogenesis of APP infection. Further studies on affected 
lung lesions should be carried out in future studies to deci-
pher the exact role of IL-10 in APP infections.
Finally, we observed that the frequency of Th17 cells in 
lung and PBMCs from chronically infected animals cor-
related positively with the lung lesion score and APP-spe-
cific antibody titers. Such a correlation was not found in 
the animals during the acute infection phase. This could 
be related to the enormous variety of lung lesions (dif-
fuse/local necrotic and hemorrhagic areas, fibrosis, for-
mation of sequestra, absence of lesions) observed at the 
necropsy during the acute phase, as described above. 
Moreover, no positive correlation between Th17 cells and 
the histological score of lung tissue samples from which 
lymphocytes had been isolated was found in the chronic 
phase of infection. Together with the positive correlation 
between frequency of Th17 cells in lung tissue as well as 
blood and the lung lesion score, this may indicate that 
these APP-specific Th17 cells have a general capacity for 
lung homing and also recirculate via the bloodstream. 
This would correspond with functional attributes ascribed 
to effector memory T cells [54]. However, the precise 
functional role of these Th17 cells in APP pathology and 
persistence remains speculative. It is well established that 
cytokine production by Th17 cells can have protective but 
also pathologic roles in lung immunity [19]. An exces-
sive recruitment of neutrophils due to IL-17 production 
by CD4+ T cells could lead to progressive inflammation, 
which might explain the positive correlation between lung 
lesion and IL-17 production. Additionally, APP chronic 
lung lesions are usually characterized by fibroplasia [1] 
and IL-17 was shown to be involved in the occurrence and 
the development of pulmonary fibrosis in rats [55]. Nev-
ertheless, our in vitro stimulation system does not allow 
a distinction between actively IL-17A-producing CD4+ T 
cells in vivo (at the time of isolation) and the re-stimula-
tion of quiescent APP-specific Th17 memory cells upon 
a second exposure to the antigen. Therefore, the precise 
role of the putative APP-specific Th17 cells in APP immu-
nity, identified in our study, remains to be elucidated.
In conclusion, our results support previous findings 
that T cells are involved in the immune response to APP 
infection. We could show for the first time that APP-spe-
cific T cells with functional attributes of Th17 cells are 
induced in most APP-infected animals, which during the 
chronic phase of infection seem to positively correlate 
with lung lesion formation. Thus, our findings highlight 
the relevance of detailed immunological studies address-
ing T-cell differentiation for a better understanding of 
host-pathogen interactions in APP. Moreover, our infec-
tion model provides a solid basis for such studies in a 
controlled setting. This will contribute to a better under-
standing of APP pathogenesis and persistence.
Additional files
Additional file 1. Clinical score protocol. Clinical examinations were 
performed daily throughout the experiment. Alterations in behavior, 
gait, presence of respiratory symptoms (cough and dyspnea), and body 
temperature were assessed and scored on a scale from 0 to 4 based on 
the listed symptoms or traits.
Additional file 2. FCM gating hierarchy. Representative example of 
the FCM gating strategy used in this study. Data is derived from lung of 
animal #12 (APP‑infected). (A) Lymphocytes were gated according to 
their light scatter properties. (B) A FSC‑W/H gate coupled with a SSC‑W/H 
gate was applied in order to exclude potential doublet cells. (C) Near‑IR 
stain was used for Live/Dead discrimination. Only Near‑IR negative cells 
(live cells) were included in the following analyses. (D) Co‑expression of 
CD4 and IL‑17A for identification of IL‑17A+ CD4+ T cells. (E) Cells were 
further distinguished in either CD4+ or CD4− T cells. (F) Within the CD4+ 
subpopulation, the production of IL‑17A and TNF‑α was investigated. (G) 
Within the CD4− subpopulation, the expression of IL‑17A and TCR‑γδ was 
investigated.
Additional file 3. Pathological findings in the lung of acutely and 
chronically infected animals. Lungs from representative animals, one 
for the acute and one for the chronic phase, are shown. (A) Bilateral dif‑
fuse hemorrhagic pneumonia and fibrinous pleurisy in an acutely infected 
animal (#3). (B) Necrotic foci surrounded by scar tissue (sequestra) and 
adhesive pleurisy with evidence of firm adhesions between visceral and 
parietal pleura in a chronically infected animal (#11).
Additional file 4. Histological evaluation of lung tissue from 
infected animals. Lung tissue of the dorsal portion of left caudal lung 
lobe (adjacent to samples used for lymphocyte isolation) was taken from 
acutely and chronically infected animals. This tissue was paraffin embed‑
ded, stained with hematoxylin and eosin, and examined for presence and 
quantity of parameters A–H (see legend). The quantity and presence of 
each parameter were assessed by using a score from 0 to 3 (0 = not pre‑
sent, 1 = low grade, 2 = moderate grade, 3 = high grade). No sample in 
this study presented lesions of grade 3; therefore this grade is not shown 
in the legend.
Additional file 5. APP-specific induction of IL-17A+ CD4+ T cells in 
peripheral blood. PBMCs were incubated overnight with APP crude cap‑
sular extract (APP‑CCE), medium or PMA/Ionomycin. Living lymphocytes 
were gated (not shown; see Additional file 1) and further analyzed for 
the expression of IL‑17A and CD4. Data from representative animals from 
different groups are displayed: #5 and #4 for the acute phase, designated 
as “high responder” and “low responder” respectively; #11 and #17 for the 
chronic phase designated as “high responder” and “low responder” respec‑
tively; #6, designated as non‑responder and control pig #23. Approxi‑
mately 7 × 105 (APP and medium) and 2 × 105 (PMA/Ionomycin) cells are 
shown in the contour plots respectively. Numbers displayed within the 
contour plots indicate the percentage of IL‑17A+CD4+ T cells within total 
CD4+ T cells.
Additional file 6. Expression of CD8α by IL-17A+ CD4+ T cells in 
peripheral blood. PBMCs were incubated overnight with APP crude 
capsular extract (APP‑CCE), medium or PMA/Ionomycin. Living lympho‑
cytes were gated (not shown; see Additional file 1) and further analyzed 
for the expression of CD8α and IL‑17A. Data from the same animals as in 
Additional file 2 is shown. Approximately 3 × 105 (APP and medium) and 
5 × 104 (PMA/Ionomycin) cells are shown in the contour plots.
Additional file 7. Co-production of TNF-α and IL-17A by CD4+ T 
cells in peripheral blood. Phenotyping and intracellular cytokine stain‑
ing were performed on PBMC following overnight in vitro stimulation 
(APP‑CCE, medium, PMA/Ionomycin). (A) Living CD4+ T cells were gated 
(not shown; see Additional file 1) and further analyzed for production of 
TNF‑α and IL‑17A. Data from the same animals as in Additional file 2 are 
shown. Approximately 3 × 105 (APP and medium) and 5 × 104 (PMA/
Ionomycin) cells are shown in the contour plots. (B) Frequency of IL‑17A/
TNF‑α co‑producing CD4+ T cells in PBMC of infected animals (red dots) 
and control animals (blue dots) during acute and chronic phase. Numbers 
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